| Primary |
| Hypercholesterolaemia |
48.5% |
| Hypertension |
20.8% |
| Hyperlipidaemia |
6.9% |
| Asthma |
3.0% |
| Diabetes Mellitus |
3.0% |
| Blood Cholesterol Increased |
2.0% |
| Coronary Artery Disease |
2.0% |
| Low Density Lipoprotein Increased |
2.0% |
| Back Pain |
1.0% |
| Benign Prostatic Hyperplasia |
1.0% |
| Blood Cholesterol |
1.0% |
| Cardiovascular Event Prophylaxis |
1.0% |
| Depression |
1.0% |
| Dystonia |
1.0% |
| Hypothyroidism |
1.0% |
| Influenza Immunisation |
1.0% |
| Ischaemic Heart Disease Prophylaxis |
1.0% |
| Metabolic Acidosis |
1.0% |
| Pain |
1.0% |
| Prophylaxis |
1.0% |
|
| Tendon Rupture |
10.0% |
| Myalgia |
7.5% |
| Osteoarthritis |
7.5% |
| Osteolysis |
7.5% |
| Hypertension |
5.0% |
| Low Density Lipoprotein Increased |
5.0% |
| Macular Degeneration |
5.0% |
| Overdose |
5.0% |
| Periostitis |
5.0% |
| Pyrexia |
5.0% |
| Rhabdomyolysis |
5.0% |
| Sensory Disturbance |
5.0% |
| Syncope |
5.0% |
| Tooth Loss |
5.0% |
| White Blood Cell Count Increased |
5.0% |
| Blood Triglycerides Increased |
2.5% |
| Electrocardiogram Qt Prolonged |
2.5% |
| Foot Fracture |
2.5% |
| Gastrooesophageal Sphincter Insufficiency |
2.5% |
| Haematuria |
2.5% |
|
| Secondary |
| Hypertension |
31.3% |
| Hypercholesterolaemia |
14.0% |
| Drug Use For Unknown Indication |
12.3% |
| Hyperlipidaemia |
5.0% |
| Prophylaxis |
4.5% |
| Type 2 Diabetes Mellitus |
3.4% |
| Cardiac Failure |
2.8% |
| Hyperparathyroidism |
2.8% |
| Hypothyroidism |
2.8% |
| Pain |
2.8% |
| Thrombosis Prophylaxis |
2.8% |
| Acidosis |
2.2% |
| Anaemia |
2.2% |
| Cardiovascular Event Prophylaxis |
2.2% |
| Gastroenteritis |
1.7% |
| Helicobacter Gastritis |
1.7% |
| Hyperuricaemia |
1.7% |
| Mineral Supplementation |
1.7% |
| Blood Cholesterol Increased |
1.1% |
| Clostridial Infection |
1.1% |
|
| Rhabdomyolysis |
9.7% |
| Syncope |
9.7% |
| Intentional Overdose |
6.5% |
| Muscular Weakness |
6.5% |
| Renal Function Test Abnormal |
6.5% |
| Sensory Disturbance |
6.5% |
| Suicide Attempt |
6.5% |
| Vascular Graft |
6.5% |
| White Blood Cell Count Increased |
6.5% |
| Circulatory Collapse |
3.2% |
| Drug Intolerance |
3.2% |
| Dyspnoea Exertional |
3.2% |
| Low Density Lipoprotein Increased |
3.2% |
| Metabolic Disorder |
3.2% |
| Muscle Atrophy |
3.2% |
| Musculoskeletal Pain |
3.2% |
| Myocardial Infarction |
3.2% |
| Myoglobin Blood Increased |
3.2% |
| Prothrombin Time Abnormal |
3.2% |
| Renal Failure |
3.2% |
|
| Concomitant |
| Hypertension |
21.3% |
| Prophylaxis Against Renal Transplant Rejection |
12.0% |
| Product Used For Unknown Indication |
10.3% |
| Coronary Artery Disease |
6.2% |
| Renal Transplant |
5.4% |
| Prophylaxis Against Transplant Rejection |
5.2% |
| Drug Use For Unknown Indication |
4.9% |
| Cardiac Failure |
3.7% |
| Prophylaxis |
3.7% |
| Pain |
3.4% |
| Hypercholesterolaemia |
3.3% |
| Hyperlipidaemia |
3.1% |
| Cardiovascular Event Prophylaxis |
2.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.4% |
| Abdominal Pain Upper |
2.3% |
| Osteoporosis |
2.1% |
| Type 2 Diabetes Mellitus |
2.1% |
| Non-small Cell Lung Cancer |
2.0% |
| Atrial Fibrillation |
1.9% |
| Bronchial Carcinoma |
1.8% |
|
| Somnolence |
8.3% |
| Syncope |
8.3% |
| Vomiting |
8.3% |
| Urinary Tract Infection |
7.3% |
| Weight Decreased |
7.3% |
| Urosepsis |
6.4% |
| Hypotension |
5.5% |
| Myocardial Infarction |
5.5% |
| Nausea |
5.5% |
| Cerebral Haemorrhage |
4.6% |
| Thrombocytopenia |
4.6% |
| Cardiac Failure |
3.7% |
| Pancreatitis Acute |
3.7% |
| Urinary Retention |
3.7% |
| Weight Increased |
3.7% |
| Aplasia Pure Red Cell |
2.8% |
| Death |
2.8% |
| Renal Failure Acute |
2.8% |
| Transaminases Increased |
2.8% |
| Ureteric Stenosis |
2.8% |
|
